TB-500 for heart health in stable artery disease
Part of Heart & circulation clinical trials.
This study tests if TB-500 can improve blood markers of cardiovascular health in people with stable artery disease. It is an early-phase trial to see if the drug is safe and shows promise.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 75 years old.
- You have stable heart or artery disease (for example, a past heart attack more than 6 months ago, a stent or bypass, or blocked leg arteries).
- You are already on standard medications (like a statin and a blood thinner) for at least 8 weeks.
- Your blood pressure is controlled (below 160/100).
- You have not had a heart attack, stroke, or heart procedure in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication, AZD0780, to see if it helps prevent major cardiovascular events like heart attacks or strokes in people who already have heart or blood vessel disease, or are at high risk for a first event. It might be a good fit if your cholesterol isn't well-controlled despite current treatments.
This study tests a new treatment, NTLA-2001, for people with a type of heart disease called transthyretin amyloidosis with cardiomyopathy. It aims to see if the medicine can help improve heart function and quality of life.
This study tests a new medicine for heart health in healthy volunteers. It aims to see how the body handles the medicine when taken alone or with another medicine, and if it is safe.
This trial studies whether atorvastatin (a cholesterol medicine) can reduce ongoing inflammation after you finish standard tuberculosis (TB) treatment. If it works, it may improve how your body recovers after TB, especially by lowering inflammation-related signals.
This study tests an investigational medicine called HRS9531 for people with atherosclerotic cardiovascular disease (a buildup of plaque in the arteries that can lead to heart attacks and strokes). The trial aims to see if the medicine helps reduce risks in this condition.
This study tests whether TA-65, a supplement, can improve blood vessel function in healthy younger and older adults, and in people with coronary artery disease (narrowed heart arteries). It may help understand aging-related blood vessel problems.
Hear when a new Endothelial Dysfunction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.